1. Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome.
- Author
-
LIBÁNSKÝ, Petr, ČARKOVÁ, Jitka, KUSHNIR, Ivan, MATĚJKOVÁ BĚHANOVÁ, Magdalena, PROCYKLOVÁ, Kristýna, ŠEDÝ, Jiří, VACULOVÁ, Markéta, VČELÁK, Josef, ZIKÁN, Vít, and ADÁMEK, Svatopluk
- Subjects
HYPERPARATHYROIDISM treatment ,ENDOCRINE gland tumors ,HYPERPARATHYROIDISM ,GENETIC testing ,PARATHYROID glands ,REOPERATION ,ADENOMA ,PATIENTS' attitudes - Abstract
Primary hyperparathyroidism is a common endocrinopathy. Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare autosomal dominantly inherited endocrine tumor predisposition syndrome, with one of main manifestations being primary hyperpara-thyroidism. We retrospectively evaluated a set of 1011 patients who underwent surgery for primary hyperparathyroidism between the years 2018--2022, and found 78 (8 %) patients who underwent reoperations and 27 patients with MEN1 syndrome. In the group of patients with MEN1 syndrome, 7 (35 %) needed reoperations. Patients with multiple endocrine neoplasia syndrome have a higher risk of needing reoperation. Genetic testing can help identify MEN1 syndrome preoperatively and to better evaluate the approach to surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF